News
NOTV
1.800
+4.65%
0.080
Weekly Report: what happened at NOTV last week (0610-0614)?
Weekly Report · 5d ago
Analysts Offer Insights on Healthcare Companies: Semler Scientific (SMLR) and Inotiv (NOTV)
TipRanks · 06/10 13:00
Inotiv (NOTV) Receives a Buy from Craig-Hallum
TipRanks · 06/10 12:45
Inotiv Completes Hillcrest, UK Expansion, Secures Long-Term Contracts with New Customers
Hillcrest, U.K. Expansion project completed Extension of the maturity date of the $3.7 million OBRC payable note to July 2025. Inotiv is a leading contract research organization specializing in nonclinical and analytical drug discovery and development services.
Benzinga · 06/10 11:37
INOTIV, INC. PROVIDES BUSINESS UPDATES
Reuters · 06/10 11:30
INOTIV INC: EXTENSION OF MATURITY DATE OF $3.7 MLN OBRC PAYABLE NOTE TO JULY 2025
Reuters · 06/10 11:30
Weekly Report: what happened at NOTV last week (0603-0607)?
Weekly Report · 06/10 10:48
Analysts Offer Insights on Healthcare Companies: Inotiv (NOTV), Dexcom (DXCM) and CareDx (CDNA)
TipRanks · 06/04 13:20
Analysts Conflicted on These Healthcare Names: Inotiv (NOTV), BioNTech SE (BNTX) and Augmedix (AUGX)
TipRanks · 06/04 13:01
12 Health Care Stocks Moving In Monday's After-Market Session
Gainers FibroGen stock moved upwards by 24.4% to $1.53 during Monday's after-market session. Candel Therapeutics (NASDAQ:CADL) stock increased by 8.12%. Scholar Rock Holding shares rose 6.96% in the after- market. Losers Bright Green and Concord Medical Services stock fell 7.4%.
Benzinga · 06/03 20:31
UPDATE 1-US breeder Envigo pleads guilty for mistreating beagles, gets $22 million fine
US breeder Envigo pleads guilty for mistreating beagles, gets $22 million fine for animal welfare violations. Indiana-based company agreed to pay $11 million in the largest-ever fine in an animal welfare case. Some 4,000 beagles were euthanized and some adopted by celebrities.
Reuters · 06/03 18:31
Inotiv to Pay $35M for Canine-Breeding Facility Violations
Dow Jones · 06/03 18:00
INOTIV REACHES AGREEMENT TO RESOLVE PREVIOUSLY-ANNOUNCED INVESTIGATION INTO SHUTTERED CUMBERLAND FACILITY
Reuters · 06/03 17:24
INOTIV-REACHED AGREEMENT WITH DOJ TO RESOLVE PREVIOUSLY-ANNOUNCED CRIMINAL INVESTIGATION INTO SHUTTERED CANINE BREEDING FACILITY LOCATED IN CUMBERLAND
Reuters · 06/03 17:24
Inotiv's Envigo Pleads Guilty Over Its Mistreatment Of Beagles; Envigo Will Pay Total Of $35M In Fines And Funds For Environmental And Animal Welfare Causes
Benzinga · 06/03 16:43
REFILE-US breeder Envigo pleads guilty for mistreating beagles, gets largest-ever fine
US breeder Envigo pleads guilty for mistreating beagles, gets largest-ever fine in animal welfare case. The company agreed to pay $22 million in fines, plus $13.5 million to support animal welfare projects. The Justice Department probe stemmed from its mistreatment of thousands of beagles. Some of the dogs were adopted by celebrities including Prince Harry.
Reuters · 06/03 16:40
Weekly Report: what happened at NOTV last week (0527-0531)?
Weekly Report · 06/03 10:50
Weekly Report: what happened at NOTV last week (0520-0524)?
Weekly Report · 05/27 10:54
Inotiv Inc: Securities to be offered to employees in employee benefit plans, post-effective amendments
Press release · 05/25 00:11
Inotiv, Inc. to Participate in Upcoming Craig Hallum and Jefferies Investor Conferences
Inotiv, Inc. Will participate in the upcoming 21st Annual Craig Hallum Institutional Investor Conference and Jefferies Global Healthcare Conference. Inotiv is a leading contract research organization specializing in drug discovery and development services. The company's CEO and CFO will be in attendance.
Barchart · 05/23 15:15
More
Webull provides a variety of real-time NOTV stock news. You can receive the latest news about Inotiv Inc through multiple platforms. This information may help you make smarter investment decisions.
About NOTV
Inotiv, Inc. is a contract research company, which is engaged in providing nonclinical and analytical drug discovery and development services to the pharmaceutical and medical device industries and selling a range of research-quality animals and diets to the same industries, as well as academia and government clients. Its products and services focus on bringing new drugs and medical devices through the discovery and preclinical phases of development. It operates through two segments: Discovery and Safety Assessment (DSA) and Research Models and Services (RMS). The DSA segment supports the discovery, nonclinical development and clinical development needs of researchers and clinicians for primarily small molecule drug candidates, as well as biotherapeutics and biomedical devices. The RMS segment offer access to a range of small and large research models for basic research and drug discovery and development, as well as specialized models for specific diseases and therapeutic areas.